diabetes

Progressing through Hybrid and “Fully” Closed-looping

I’ve done articles like this in the past, comparing my clinical results over the years. But I’ve just hit what feels like another milestone, so I’m going to re-do it using my current reporting tools. I’m going to show data from four points in time: 2017, when I’d only recently started using an Automated Insulin …

Progressing through Hybrid and “Fully” Closed-looping Read More »

Ranges and Timeframes

I recently wrote about the value of HbA1c in measuring more than just our average BG level. And in fact that it’s often not accurate in that. Our best tools for measuring our BG patterns at the moment are Continuous Glucose Monitoring (CGM) systems. Basic data CGM data can show us is how much our …

Ranges and Timeframes Read More »

Does HbA1c have value?

This is a question we often see discussed, but I think some of those discussions miss an important issue which I’m going to explore here. The HbA1c blood test shows us how much of the haemoglobin in our blood has been “glycated” (bonded with glucose). We’re often shown that value in the context of trying …

Does HbA1c have value? Read More »

A reprieve for Fiasp

The sudden removal of the fast-acting Fiasp insulin from Australia’s PBS subsidy system has been a source of major heartache amongst the diabetes community. But we had a glimmer of hope this morning. The Federal Health Minister (Mark Butler MP) has announced that instead of Fiasp being summarily deleted from PBS, it’s going into “Supply …

A reprieve for Fiasp Read More »